The hematopoietic transcription factor PU.1 regulates RANK gene expression in myeloid progenitors

被引:49
作者
Kwon, OH
Lee, CK
Lee, YI
Paik, SG
Lee, HJ
机构
[1] System Proteom Res Ctr, Korea Res Inst Biosci & Biotechnol, Taejon 305333, South Korea
[2] Chungbuk Natl Univ, Coll Pharm, Cheongju, South Korea
[3] Korea Res Inst Biosci & Biotechnol, Liver Cell Signal Transduct Lab, Taejon 305333, South Korea
[4] Chungnam Natl Univ, Sch Biosci & Biotechnol, Dept Biol, Chungnam, South Korea
基金
新加坡国家研究基金会;
关键词
osteoclast; PU.1; RANK; M-CSF; transcription factor; promoter; differentiation; hematopoiesis;
D O I
10.1016/j.bbrc.2005.07.092
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
Osteoclasts are bone resorbing cells of hematopoietic origin. The hematopoietic transcription factor PU.1 is critical for osteoclastogenesis; however, the molecular mechanisms of PU.1 -regulated osteoclastogenesis have not been explored. Here, we present evidence that the receptor activator of nuclear factor kappa B (RANK) gene that has been shown to be crucial for osteoclastogenesis is a transcriptional target of PU.1. The PU.1(-/-) progenitor cells failed to express the RANK gene and reconstitution of PU.1 in these cells induced RANK expression. Treatment of the PU.1 reconstituted cells with M-CSF and RANKL further augmented the RANK gene expression. To explore the regulatory mechanism of the RANK gene expression by PU.1, we have cloned the human RANK promoter. Transient transfection assays have revealed that the 2.2-kb RANK promoter was functional in a monocyte line RAW264.7, whereas co-transfection of PU.1 transactivated the RANK promoter in HeLa cells. Taken together, these results suggest that PU.1 regulates the RANK gene transcription and this may represent one of the key roles of PU.1 in osteoclast differentiation. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:437 / 446
页数:10
相关论文
共 34 条
[1]
A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function [J].
Anderson, DM ;
Maraskovsky, E ;
Billingsley, WL ;
Dougall, WC ;
Tometsko, ME ;
Roux, ER ;
Teepe, MC ;
DuBose, RF ;
Cosman, D ;
Galibert, L .
NATURE, 1997, 390 (6656) :175-179
[2]
Constitutive expression of PU.1 in fetal hematopoietic progenitors blocks T cell development at the pro-T cell stage [J].
Anderson, MK ;
Weiss, AH ;
Hernandez-Hoyos, G ;
Dionne, CJ ;
Rothenberg, EV .
IMMUNITY, 2002, 16 (02) :285-296
[3]
Commitment and differentiation of osteoclast precursor cells by the sequential expression of c-Fms and receptor activator of nuclear factor κB (RANK) receptors [J].
Arai, F ;
Miyamoto, T ;
Ohneda, O ;
Inada, T ;
Sudo, T ;
Brasel, K ;
Miyata, T ;
Anderson, DM ;
Suda, T .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 190 (12) :1741-1754
[4]
Osteoclast differentiation and activation [J].
Boyle, WJ ;
Simonet, WS ;
Lacey, DL .
NATURE, 2003, 423 (6937) :337-342
[5]
Pip, a lymphoid-restricted IRF, contains regulatory domain that is important for autoinhibition and ternary complex formation with the Ets factor PU.1 [J].
Brass, AL ;
Kehrli, E ;
Eisenbeis, CF ;
Storb, U ;
Singh, H .
GENES & DEVELOPMENT, 1996, 10 (18) :2335-2347
[6]
CHEN HM, 1993, J BIOL CHEM, V268, P8230
[7]
PU.1 regulates expression of the interleukin-7 receptor in lymphoid progenitors [J].
DeKoter, RP ;
Lee, HJ ;
Singh, H .
IMMUNITY, 2002, 16 (02) :297-309
[8]
PU.1 regulates both cytokine-dependent proliferation and differentiation of granulocyte/macrophage progenitors [J].
DeKoter, RP ;
Walsh, JC ;
Singh, H .
EMBO JOURNAL, 1998, 17 (15) :4456-4468
[9]
RANK is essential for osteoclast and lymph node development [J].
Dougall, WC ;
Glaccum, M ;
Charrier, K ;
Rohrbach, K ;
Brasel, K ;
De Smedt, T ;
Daro, E ;
Smith, J ;
Tometsko, ME ;
Maliszewski, CR ;
Armstrong, A ;
Shen, V ;
Bain, S ;
Cosman, D ;
Anderson, D ;
Morrissey, PJ ;
Peschon, JJ ;
Schuh, J .
GENES & DEVELOPMENT, 1999, 13 (18) :2412-2424
[10]
MACROPHAGE COLONY STIMULATING FACTOR RESTORES INVIVO BONE-RESORPTION IN THE OP/OP OSTEOPETROTIC MOUSE [J].
FELIX, R ;
CECCHINI, MG ;
FLEISCH, H .
ENDOCRINOLOGY, 1990, 127 (05) :2592-2594